Online citations, reference lists, and bibliographies.
← Back to Search

Predictors Of Recurrence In Bipolar Disorder: Primary Outcomes From The Systematic Treatment Enhancement Program For Bipolar Disorder (STEP-BD).

R. Perlis, M. Ostacher, J. Patel, L. Marangell, Hongwei Zhang, S. Wisniewski, T. Ketter, D. Miklowitz, M. Otto, L. Gyulai, N. Reilly-Harrington, A. Nierenberg, G. Sachs, M. Thase
Published 2006 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVE Little is known about clinical features associated with the risk of recurrence in patients with bipolar disorder receiving treatment according to contemporary practice guidelines. The authors looked for the features associated with risk of recurrence. METHOD The authors examined prospective data from a cohort of patients with bipolar disorder participating in the multicenter Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study for up to 24 months. For those who were symptomatic at study entry but subsequently achieved recovery, time to recurrence of mania, hypomania, mixed state, or a depressive episode was examined with Cox regression. RESULTS Of 1,469 participants symptomatic at study entry, 858 (58.4%) subsequently achieved recovery. During up to 2 years of follow-up, 416 (48.5%) of these individuals experienced recurrences, with more than twice as many developing depressive episodes (298, 34.7%) as those who developed manic, hypomanic, or mixed episodes (118, 13.8%). The time until 25% of the individuals experienced a depressive episode was 21.4 weeks and until 25% experienced a manic/hypomanic/mixed episode was 85.0 weeks. Residual depressive or manic symptoms at recovery and proportion of days depressed or anxious in the preceding year were significantly associated with shorter time to depressive recurrence. Residual manic symptoms at recovery and proportion of days of elevated mood in the preceding year were significantly associated with shorter time to manic, hypomanic, or mixed episode recurrence. CONCLUSIONS Recurrence was frequent and associated with the presence of residual mood symptoms at initial recovery. Targeting residual symptoms in maintenance treatment may represent an opportunity to reduce risk of recurrence.
This paper references
10.1192/BJP.133.5.429
A rating scale for mania: reliability, validity and sensitivity.
R. Young (1978)
10.1192/BJP.134.4.382
A new depression scale designed to be sensitive to change.
S. Montgomery (1979)
10.1001/JAMA.255.22.3138
Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness.
M. Keller (1986)
10.1001/ARCHPSYC.1990.01810240026005
Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis.
M. Tohen (1990)
10.1001/ARCHPSYC.1990.01810190065009
Outcome in manic disorders. A naturalistic follow-up study.
M. Harrow (1990)
10.1001/ARCHPSYC.1992.01820050035005
Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium.
M. Keller (1992)
10.1093/SCHBUL/18.2.273
The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome.
M. Tohen (1992)
10.1097/00005053-199304000-00005
Bipolar I: A Five-Year Prospective Follow-up
M. Keller (1993)
10.1016/0165-0327(94)90104-X
The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members.
J. Lish (1994)
10.1176/AJP.152.3.379
Course and outcome in bipolar affective disorder: a longitudinal follow-up study.
J. Goldberg (1995)
10.1176/AJP.152.11.1635
Relapse and impairment in bipolar disorder.
M. Gitlin (1995)
Course of illness and maintenance treatments for patients with bipolar disorder.
D. Solomon (1995)
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D. Sheehan (1998)
10.4088/JCP.V60N0104
Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs.
M. Bauer (1999)
10.1080/hrp_8.3.126
Effectiveness of Psychosocial Treatments in Bipolar Disorder: State of the Evidence
N. Huxley (2000)
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
G. Sachs (2000)
10.1016/S0025-7125(05)70332-1
The role of psychotherapy in treating psychiatric disorders.
W. E. Craighead (2001)
10.4088/JCP.V63N0206
Demographic and clinical characteristics of individuals in a bipolar disorder case registry.
D. Kupfer (2002)
10.1034/J.1399-5618.2002.01195.X
A clinical monitoring form for mood disorders.
G. Sachs (2002)
Remission as the critical outcome of depression treatment.
M. Thase (2002)
10.1001/ARCHPSYC.59.6.530
The long-term natural history of the weekly symptomatic status of bipolar I disorder.
L. Judd (2002)
10.1001/ARCHPSYC.60.3.261
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.
L. Judd (2003)
10.1176/APPI.AJP.160.12.2099
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
M. Tohen (2003)
10.1034/J.1399-5618.2003.00013.X
The effect of previous mood states on switch rates: a naturalistic study.
M. Gitlin (2003)
10.1001/ARCHPSYC.60.4.402
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.
F. Colom (2003)
10.1001/ARCHPSYC.60.9.904
A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder.
D. Miklowitz (2003)
10.1016/S0165-0327(01)00460-8
Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder.
M. Otto (2003)
10.4088/JCP.V64N0403
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
T. Suppes (2003)
10.1016/S0006-3223(03)00165-3
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
G. Sachs (2003)
10.4088/JCP.V65N0321
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
G. Goodwin (2004)
10.1176/APPI.AJP.161.12.2222
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
N. Simon (2004)
10.1007/s00127-005-0864-7
Time to remission and relapse after the first hospital admission in severe bipolar disorder
E. Bromet (2005)
10.4088/JCP.v66n0702
The Texas implementation of medication algorithms update for treatment of bipolar I disorder.
R. Perlis (2005)
10.1017/S0033291704002624
Randomized trial of a population-based care program for people with bipolar disorder
G. Simon (2005)
10.1176/APPI.AJP.162.7.1281
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
M. Tohen (2005)



This paper is referenced by
10.3389/fpsyt.2021.617640
Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study
T. Hayasaka (2021)
10.1016/j.psychres.2021.113824
Sleep alterations in individuals recently diagnosed with bipolar disorder across different mood stages
I. S. Vieira (2021)
10.1016/j.euroneuro.2020.11.001
Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
M. Ioannou (2021)
10.1111/acps.13287
Preventive effect of morning light exposure on relapse into depressive episode in bipolar disorder
Y. Esaki (2021)
10.3389/fpsyt.2021.641241
Monitoring Sleep Changes via a Smartphone App in Bipolar Disorder: Practical Issues and Validation of a Potential Diagnostic Tool
F. Fellendorf (2021)
10.1177/02698811211015224
A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression
M. McCarthy (2021)
10.1177/20451253211000612
Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder
Mutahira M Qureshi (2021)
10.1186/s12888-021-03133-1
A surrogate measure for patient reported symptom remission in administrative data
F. Alemi (2021)
10.1016/j.jad.2020.12.199
Inferior frontal gyrus seed-based resting-state functional connectivity and sustained attention across manic/hypomanic, euthymic and depressive phases of bipolar disorder.
Hua Yu (2021)
10.1016/j.psychres.2021.113995
Residual symptoms in bipolar disorders: Findings from the bipolar Disorder course and outcome study from India (BiD-CoIN study)
S. Grover (2021)
10.1016/j.jpsychires.2021.02.031
A practical overview and decision tool for analyzing recurrent events in mental illness: A review.
T. Kaster (2021)
10.21203/RS.3.RS-589028/V1
Pareidolia in Schizophrenia and Bipolar Disorder
Eid G. Abo Hamza (2021)
10.1155/2021/8816390
Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis
M. Sussman (2021)
10.2196/26348
Validity of the Aktibipo Self-rating Questionnaire for the Digital Self-assessment of Mood and Relapse Detection in Patients With Bipolar Disorder: Instrument Validation Study
Jiri Anyz (2021)
10.2147/NDT.S322507
Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project
Yusuke Konno (2021)
10.1017/9781108646765.015
Bipolar Affective Disorder in Men
A. Young (2021)
10.1016/j.jpsychires.2020.09.030
Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).
Masaki Kato (2020)
10.1080/07420528.2020.1746799
Association between light exposure at night and manic symptoms in bipolar disorder: cross-sectional analysis of the APPLE cohort
Y. Esaki (2020)
10.1016/j.jad.2020.03.018
Remission and recurrence in bipolar disorder: The data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study.
J. V. Pinto (2020)
10.1016/j.jad.2020.07.109
The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials.
M. Fornaro (2020)
10.1155/2020/8986014
Relapse and Clinical Characteristics of Patients with Bipolar Disorders in Central Ethiopia: A Cross-Sectional Study
Habte Belete (2020)
10.1111/bdi.13036
The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary
G. Malhi (2020)
10.1016/j.jad.2020.08.079
Determinants of the remission heterogeneity in bipolar disorders: The importance of early maladaptive schemas (EMS).
C. Munuera (2020)
10.22201/fm.24484865e.2020.63.6.06
Manejo y comorbilidades de los trastornos bipolares en la infancia y adolescencia
H. E. Hernández-Martínez (2020)
10.1017/s109285292000156x
Adjunctive treatment with psychostimulants and stimulant-like drugs for resistant bipolar depression: a systematic review and meta-analysis.
E. Tsapakis (2020)
10.23736/s0391-1772.20.02072-5
Psychiatric social work intervention and social functioning for people with bipolar affective disorder: a randomized control trial
A. Saha (2020)
10.4103/psychiatry.IndianJPsychiatry_760_19
Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: An exploratory study
S. Grover (2020)
10.1080/01612840.2020.1821139
Impact of Mindfulness-Based Cognitive Therapy on Depressive Symptoms Reduction among Depressed Patients in Nigeria: A Randomized Controlled Trial
Zulkiflu Argungu Musa (2020)
10.1016/j.genhosppsych.2020.11.003
Distribution of agitation and related symptoms among hospitalized patients using a scalable natural language processing method.
K. Hart (2020)
10.1016/j.mhpa.2020.100352
Is there a relationship between physical activity and residual mood symptoms in patients with bipolar I disorder?
K. Miranda-Pettersen (2020)
10.1007/s10608-020-10148-7
Residual Anxiety in Patients with Bipolar Disorder in Full or Partial Remission: Metacognitive Beliefs and Neurocognitive Function
M. L. Reinholdt-Dunne (2020)
10.1016/j.jad.2020.09.119
Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review.
I. Seeberg (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar